PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -98.6% | 500 | -97.8% | 0.00% | -100.0% |
| Q1 2017 | $215,000 | – | 22,825 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |